ETS1 and ovarian carcinoma: Thereby, LPA‐induced ETS‐1 was found to maintain the invasive potency of ovarian cancer cells in two key aspects, first, by switching the metabolic dependency of the cancer cells towards increased glycolysis, and second, by regulating the expression of MMPs in a cell‐type specific manner.